title: Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
abstract: OBJECTIVE
  To use data from the BreastSurgANZ Quality Audit (BQA) to examine the patterns of completion axillary lymph node dissection (cALND) after sentinel lymph node (SLN) biopsy in women treated for early breast cancer in Australia and New Zealand and to compare it to the Australian and New Zealand guidelines in cases of both positive and negative SLN results.
  
  
  METHODS
  Patients were sub grouped as having primary tumours ≤3 cm and >3 cm and further analysed according to year of surgery, SLN status and final nodal status where cALND was recorded. Multivariate analysis was performed examining tumour size, grade, presence of lymphovascular invasion (LVI), HER2 and oestrogen receptor status, patient age and number of positive sentinel nodes as predictors for subsequent axillary surgery.
  
  
  RESULTS
  14879 patients were identified from 2006 to 2010. 79.8% of patients with a positive SLN result underwent cALND. Age >70 years and a greater number of involved SLN predicted no cALND among SLN positive patients. 10.3% of patients who had a negative SLN result underwent cALND. Younger age, higher grade, lymphovascular invasion and tumour size >3 cm predicted cALND among SLN negative patients.
  
  
  CONCLUSIONS
  According to the BQA from 2006 to 2010 the Australian and New Zealand guideline recommendations for SLN positive patients to have cALND and SLN negative patients not to have cALND were adhered to in 79.8% and 89.7% of cases respectively.
authors.affiliation: Department of Surgery, The Queen Elizabeth Hospital, South Australia, Australia. Electronic address: chiltonchong@hotmail.com.
authors.forename: Chilton
authors.initials: C
authors.lastname: Chong
authors.forename: David
authors.initials: D
authors.lastname: Walters
authors.forename: Primali
authors.initials: P
authors.lastname: de Silva
authors.forename: Corey
authors.initials: C
authors.lastname: Taylor
authors.forename: Andrew
authors.initials: A
authors.lastname: Spillane
authors.forename: James
authors.initials: J
authors.lastname: Kollias
authors.forename: Chris
authors.initials: C
authors.lastname: Pyke
authors.forename: Ian
authors.initials: I
authors.lastname: Campbell
authors.forename: Guy
authors.initials: G
authors.lastname: Maddern
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D001315:Australia; D001365:Axilla; D001808:Blood Vessels / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006801:Humans; D008197:Lymph Node Excision / Q000592:standards / Q000706:statistics & numerical data*; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery*; D008207:Lymphatic Metastasis; D042601:Lymphatic Vessels / Q000473:pathology; D008485:Medical Audit; D008875:Middle Aged; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D009520:New Zealand; D017410:Practice Guidelines as Topic; D021701:Sentinel Lymph Node Biopsy; D047368:Tumor Burden
keywords: Axillary lymph node dissection; Sentinel lymph node biopsy